Biguanides enhance antifungal activity against Candida glabrata

Candida spp. are the fourth leading cause of nosocomial blood stream infections in North America. Candida glabrata is the second most frequently isolated species, and rapid development of antifungal resistance has made treatment a challenge. In this study, we investigate the therapeutic potential of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shuying Xu, Marianela Feliu, Allison K. Lord, Daniel P. Lukason, Paige E. Negoro, Nida S. Khan, Zeina Dagher, Michael B. Feldman, Jennifer L. Reedy, Samantha N. Steiger, Jenny M. Tam, Alexander A. Soukas, David B. Sykes, Michael K. Mansour
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis Group 2018-12-01
Collection:Virulence
Sujets:
Candida
Candida glabrata
biguanide
drug resistance
metformin
minimum inhibitory concentration (MIC)
Accès en ligne:http://dx.doi.org/10.1080/21505594.2018.1475798
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires